查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2094402

神經外科醫療設備市場－2026-2032年全球市場預測

Neurosurgery Devices Market - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 194 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，神經外科醫療設備市場規模將成長至 331.2 億美元，複合年成長率為 10.46%。

主要市場統計數據
基準年 2025 165億美元
預計年份：2026年 181.8億美元
預測年份 2032 331.2億美元
複合年成長率 (%) 10.46%

神經外科醫療設備執行摘要：精準、安全與數位整合

隨著醫療系統面臨創傷性腦損傷、中風、腦腫瘤、水腦症、癲癇、巴金森氏症、脊髓疾病和其他複雜中樞神經系統疾病日益成長的臨床需求，神經外科醫療設備在現代神經病學中發揮核心作用。此領域涵蓋神經刺激系統、立體定位和導航平台、神經科學用內視鏡裝置、顱骨固定系統、腦脊髓液管理裝置、神經外科鑽頭和顯微鏡、神經血管裝置、超音波吸引器、機器人輔助平台以及術中監測技術。微創神經外科、影像引導介入、精準定位和手術全期安全性的提升推動了這些器械的廣泛應用。由於這些醫療設備通常植入體內，是維持生命所必需的，或用於關鍵的神經解剖手術，因此監管依然嚴格，臨床證據、生物相容性、網路安全和上市後監測至關重要。先進的診斷影像技術、混合手術室、介入性神經放射學以及多學科診療路徑的日益普及也影響著市場需求。隨著醫院將縮短手術時間、減少併發症和改善功能預後作為首要目標，神經外科醫療設備的策略正從單純追求硬體效能轉向建構一個整合的手術生態系統，該系統融合了影像、導航、規劃軟體、機器人技術、人工智慧驅動的決策支援以及時間序列患者監測等功能。

一項變革性的變化，重塑了神經外科醫療設備的引入方式。

神經外科醫療設備領域正經歷著一場由微創技術、即時成像和協作式手術平台驅動的結構性變革。傳統的開顱神經外科手術流程正被內視鏡、導管介入、立體定位和機器人輔助等方法所補充，旨在減少組織損傷並提高靶向精度。導航系統與磁振造影（MRI）、電腦斷層掃描（CT）、血管造影術攝影、纖維束成像和術中超音波的整合日益增強，使臨床醫生能夠更自信地觀察病灶、功能通路、血管結構和植入路徑。隨著機械取栓、動脈瘤治療、栓塞和血流導向技術重塑急性和慢性腦血管疾病的治療方式，神經血管介入治療也不斷擴展。植入式神經調控技術也不斷發展，深部腦部刺激、反應性刺激、脊髓刺激和周邊神經刺激均受益於更強大的程式功能、可充電系統、封閉回路型感測和個人化治療方案。同時，採購決策正轉向支援互通性、外科醫師培訓、遠距協作、高效滅菌和實證臨床方案的平台。競爭格局日益受到監管合規性、臨床數據品質、生產韌性以及透過教育、維護、軟體更新和最佳化手術流程來支持醫院的能力的影響。

人工智慧對神經外科醫療設備的累積影響

人工智慧正在為神經外科醫療設備的整個價值鏈增添新的智慧層面，涵蓋從術前規劃到術後追蹤的各個環節。在手術規劃中，人工智慧驅動的影像分割有助於識別腫瘤、出血、腦室解剖結構、血管病變和關鍵腦區，從而幫助醫療團隊最佳化手術路徑並降低可避免的風險。在手術中，機器學習可提高導航精度，支援顯微鏡和內視鏡視覺化，輔助機器人定位，並可在監測過程中實現神經生理訊號的功能映射和分析。在神經血管治療中，人工智慧驅動的影像分流已證明效用，它能夠識別主要血管閉塞、灌注不匹配和出血模式，從而在時間緊迫的情況下實現快速干預。在植入式神經調控治療中，人工智慧和先進演算法能夠利用生理訊號和患者報告結局（HRQOL）實現自適應刺激、症狀和病情檢測以及個人化治療。這些協同效應正在推動神經外科生態系統向數據豐富的模式轉型，該模式整合了影像、醫療設備遙測、電子健康記錄和臨床決策支援。然而，其實施需要具備可解釋性、在不同患者群體中檢驗、網路安全措施、監管合規性以及臨床醫生的監督。產業領導者必須將人工智慧視為臨床管理功能，而非僅將其視為一項獨立功能，並將其整合到安全、可審計且互通性的神經外科工作流程中。

全球神經外科醫療設備市場的關鍵區域洞察

在歐洲，系統性的法律規範、學術神經外科網路、全民健保或公共醫療體系，以及影像導引手術、神經調控、神經血管治療和立體定位手術的廣泛應用都在穩步推進，同時採購計劃和醫療技術評估要求也明確強調循證性、安全性、可追溯性和成本效益。在亞太地區，由於三級醫療網路的擴張、中風和創傷治療能力的提升，以及對先進影像、機器人手術和介入性神經放射學投資的增加，神經外科醫療設備正在快速現代化。中國、日本、印度、韓國和澳洲是神經外科技術應用的主要動力，儘管大都會圈和農村地區在醫療資源取得方面存在顯著差異。北美仍然是重要的影響區域，這得益於其強大的神經外科專科計畫、針對許多先進手術建立的完善的醫保報銷機制、積極的臨床試驗活動，以及導航、神經調控、神經血管介入和術中影像技術的廣泛應用。在拉丁美洲，神經外科體係正在逐步加強，巴西和墨西哥在大規模都市區醫院的應用方面處於領先地位。然而，公共部門預算限制、對進口的依賴以及專科醫生數量不平衡等問題仍然影響著醫療服務的可及性。在中東，尤其是在海灣國家，對先進醫院基礎設施、專科醫療中心和醫療技術現代化的投資正在推進，神經外科醫療設備的採用與國家醫療改革計劃和國際臨床合作密切相關。在非洲，創傷、水腦症、癲癇、先天性疾病和腫瘤的治療仍然存在大量未滿足的需求，但由於神經外科醫生密度低、影像診斷設備不足、手術室資源匱乏、維護系統不完善以及成本效益低等因素，相關技術的採用受到限制。儘管如此，培訓夥伴關係、遠端醫療和有針對性的投資正在改善一些都市區轉診醫療機構的醫療服務可近性。

小組對神經外科醫療設備策略的關鍵見解

北約成員國擁有世界上一些最先進的軍事和民間創傷救治體系，這些體系對神經外科醫療設備的需求與創傷性腦損傷的治療、神經重症監護、康復路徑、手術能力以及穩健的醫療供應鏈密切相關。在七國集團（G7）國家，由於先進的醫院系統、高密度的專科醫生、完善的臨床研究基礎設施以及針對複雜顱脊髓、神經血管和功能性神經外科手術的成熟治療路徑，神經外科醫療設備的應用普遍較為成熟。歐盟（EU）擁有嚴格的醫療設備法規，強調病人安全、臨床證據、可追溯性和上市後性能，為檢驗的神經外科技術創造了良好的環境，同時要求製造商維護完善的臨床文件和品質系統。金磚國家（BRICS）呈現出多元化的成長環境，巴西、俄羅斯、印度、中國和南非在滿足先進神經外科治療需求的同時，也面臨著醫療資源取得、國內製造業優先事項、公共採購法規以及區域醫療服務能力差異等方面的挑戰。在東南亞國協，隨著醫院基礎設施的擴建、CT和MRI普及率的提高以及對中風、創傷、脊髓和腦腫瘤治療需求的成長，神經外科醫療醫療設備的應用正在逐步推進。然而，各成員國在採購能力和專家數量方面存在顯著差異。海灣合作理事會（GCC）國家則以對先進的三級醫療設施、國際認證、數位醫療計畫和專家招募的大量投資為特徵，這些因素正在推動高階神經外科導航、機器人手術、神經血管平台和神經調控技術的應用。

主要國家的發展趨勢如何影響神經外科醫療設備的需求？

美國是神經外科醫療設備創新和臨床應用的領先中心，這得益於其龐大的手術量、專業的醫院、先進的影像技術以及神經血管、神經調控、導航和機器人輔助技術的積極應用。中國正透過醫院現代化、自主研發醫療設備、擴建中風中心以及加大對機器人和數位化手術的投資，迅速發展其神經外科醫療體系。德國的特點是其高度發展的醫院基礎設施、健全的神經外科專科體係以及導航、術中影像、神經血管介入和功能性神經外科技術的積極應用。日本的神經外科醫療設備環境極為先進，這得益於其老齡化社會和先進的醫院體系，神經血管技術、立體定位手術、影像技術和功能性神經外科技術得到了廣泛應用。在印度，創傷性腦損傷、中風、先天性疾病、脊椎疾病和腫瘤等領域存在大量未被滿足的需求，先進醫療設備的引進主要集中在大都會圈的私立醫療機構和提供三級醫療服務的公立醫療機構。在英國，醫療設備的採用受到國家醫療路徑、神經科學專科中心和系統性醫療技術評估的影響，並高度重視臨床證據和成本效益。加拿大的神經外科環境由其全民健保體系、區域轉診網路和實證採購機制所塑造，而醫療服務的可近性則取決於省級預算和候診時間管理。在法國，先進的神經外科學術水平、神經血管方面的專業知識以及完善的醫療保健報銷體系，共同促進了醫療設備在展現明確臨床價值時的應用。巴西擁有拉丁美洲最大的神經外科醫療資源之一，對創傷、中風、腫瘤、脊椎疾病和水腦症的治療需求旺盛，但進口成本和公共部門資源的限制仍然是挑戰。在墨西哥，先進的神經外科醫療體係正在主要都市區不斷擴展，但公立和私立醫療體系之間的差異影響著病患獲得昂貴的植入和醫療設備的機會。澳洲的優勢在於其強大的專科轉診網路、高標準的臨床水平，以及主要醫療中心對先進導航、神經血管和神經調控技術的應用。義大利和西班牙已建立起完善的神經外科網路，其運作受到地區醫療管理機構、學術機構以及對微創和影像導引手術需求的影響。韓國是一個技術先進的市場，擁有先進的醫院數位化水平、豐富的神經外科專業知識、對機器人手術的高度關注，以及影像引導和微創技術的快速應用。俄羅斯的主要醫療中心擁有相當的神經外科能力，但技術的可及性因地區而異，並受到採購和供應鏈狀況的影響。

為神經外科醫療設備領導企業提供的實用建議。

產業領導企業應優先考慮經臨床檢驗的創新，這些創新能夠提高手術精準度、減少併發症並支持可衡量的患者療效。隨著神經外科團隊越來越傾向於使用整合式手術生態系統而非孤立的設備，產品開發應著重於與影像、導航、機器人、電子健康記錄和醫院網路安全框架的互通性。製造商和解決方案供應商應投資於外科醫生教育、基於模擬的培訓、指導模式和服務基礎設施，尤其是在人才培養和留用直接影響產品應用的新興地區。監管策略必須具有前瞻性，納入完善的臨床證據計劃、上市後監測、人因檢驗、軟體生命週期管治以及在整合數位決策支援時實現人工智慧透明度。應透過雙重採購、組件可追溯性、滅菌相容性和區域服務體系來增強供應鏈韌性。商業策略應與以醫院為中心的價值觀保持一致，包括提高手術室效率、縮短住院時間、避免併發症、提高醫療設備的耐用性和降低整體擁有成本。在新興的醫療保健系統中，模組化平台、可擴展配置、資金籌措支援和培訓夥伴關係可以在維持安全標準的同時提高醫療服務的可近性。對於人工智慧驅動的神經外科醫療設備，領導者應專注於可解釋性、臨床醫生控制、偏差評估、隱私保護以及在真實臨床環境中的表現監測。

基於檢驗的行業證據的調查方法

本執行摘要採用二手調查方法撰寫，重點在於檢驗的公共領域和機構認可的資訊來源。分析利用了醫療設備監管指南、同行評審的神經外科和介入神經放射學文獻、關於神經系統疾病負擔的公共衛生數據、臨床實踐指南、醫院技術採納模式、報銷和醫療技術評估框架，以及影像學、神經調控、神經血管介入、機器人技術和人工智慧輔助手術等領域的現有趨勢。此外，也整合了已發表的關於醫療基礎設施指標、專科醫生供應趨勢、法規環境、公共採購趨勢和神經系統疾病診療服務可近性的證據，從而得出區域、群體和國家層面的具體見解。本調查方法不包括市場規模估算、市場佔有率計算、財務預測和推測性估計。透過交叉引用多個資訊來源，確保結論的一致性、相關性和循證性，並且說明解釋僅限於可觀察到的行業趨勢和有數據支持的醫療保健趨勢。本研究方法著重於臨床效用、監管合規性、技術採用的促進因素、准入障礙以及對神經外科醫療設備生態系統中相關人員的策略影響。

結論：神經外科醫療設備的未來在於整合與主導方法。

神經外科醫療設備正進入一個新階段，其特點是對精準干預、數位化整合、人工智慧驅動的工作流程支援以及更安全、微創的神經外科治療的需求日益成長。醫院和臨床醫生正在尋求能夠改善可視化、導航、組織保護、植入性能、神經生理監測和個人化治療的技術。區域應用將繼續受到專家資源、影像基礎設施、保險報銷、監管要求、採購重點和培訓系統的影響。成熟的醫療體係正朝著採用整合手術平台和互通性的方向發展，而新興市場則專注於擴大基礎神經外科治療的覆蓋範圍，並提供擴充性的先進醫療服務。擁有可靠的臨床證據、可互通的設計、卓越的監管合規性、可靠的服務交付以及以教育主導的推廣的行業領導者，將更有能力滿足神經外科醫生和患者不斷變化的需求。最具永續性的機會將來自那些能夠展現明確臨床價值、提高工作流程效率並維護高風險神經外科手術信任的解決方案。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章 神經外科醫療設備市場：依產品類型分類

  • 神經刺激裝置
    • 脊髓刺激設備
    • 深部腦部刺激器
    • 迷走神經刺激設備
  • 用於介入神經放射學的醫療設備
    • 腦動脈瘤栓塞術
    • 神經血管支架
  • 手術導引系統
    • 影像引導導航系統
    • 電磁導航
    • 機器人輔助導航
    • 術中映射系統
  • 內視鏡
  • 嵌入式裝置

第8章：神經外科醫療設備市場：依手術類型分類

  • 內視鏡手術
  • 雷射治療
  • 開放性手術

第9章：神經外科醫療設備市場：依病患類型分類

  • 成年患者
  • 兒童患者
  • 老年患者

第10章：神經外科醫療設備市場：依應用領域分類

  • 腫瘤手術
  • 癲癇
  • 血管疾病/中風治療
  • 水腦症治療
  • 創傷與急診神經外科
  • 脊髓疾病

第11章：神經外科醫療設備市場：依最終用戶分類

  • 醫院和專科診所
  • 門診手術中心
  • 研究和學術機構

第12章 神經外科醫療設備市場：依分銷管道分類

  • 直銷
  • 線上銷售
  • 銷售代理

第13章 神經外科醫療設備市場：依地區分類

  • 歐洲
  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 中東
  • 非洲

第14章 神經外科醫療設備市場：依組別分類

  • NATO
  • G7
  • EU
  • BRICS
  • ASEAN
  • GCC

第15章 神經外科醫療設備市場：依國家分類

  • 美國
  • 中國
  • 德國
  • 日本
  • 印度
  • 英國
  • 加拿大
  • 法國
  • 巴西
  • 墨西哥
  • 澳洲
  • 義大利
  • 韓國
  • 俄羅斯
  • 西班牙

第16章 競爭格局

  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第17章：公司簡介

  • Medtronic PLC
  • Johnson & Johnson Services, Inc.
  • Stryker Corporation
  • Boston Scientific Corporation
  • Zimmer Biomet Holdings, Inc.
  • Abbott Laboratories
  • Danaher Corporation
  • B. Braun AG
  • Koninklijke Philips NV
  • Siemens Healthineers AG
  • Olympus Corporation
  • Terumo Corporation
  • LivaNova PLC
  • Natus Medical Incorporated
  • Integra LifeSciences Corporation
  • KLS Martin SE & Co. KG
  • NAKANISHI INC.
  • Accuray Incorporated
  • Renishaw plc
  • ASAHI INTECC CO., LTD.
  • Globus Medical, Inc.
  • Synaptive Medical Inc.
  • ClearPoint Neuro, Inc.
  • Adeor Medical AG
  • Brainlab SE
  • Elekta AB
  • iVascular SLU
  • Luciole Medical AG
  • NeuroPace, Inc.
  • NuVasive, Inc.
  • Rebstock Instruments GmbH
  • Route 92 Medical, Inc.
  • Scientia Vascular, Inc.
Product Code: MRR-E370886767D8

The Neurosurgery Devices Market is projected to grow by USD 33.12 billion at a CAGR of 10.46% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 16.50 billion
Estimated Year [2026] USD 18.18 billion
Forecast Year [2032] USD 33.12 billion
CAGR (%) 10.46%

Neurosurgery Devices Executive Summary: Precision, Safety, and Digital Integration

Neurosurgery devices are becoming central to modern neurological care as health systems face rising clinical demand from traumatic brain injury, stroke, brain tumors, hydrocephalus, epilepsy, Parkinson's disease, spinal disorders, and other complex central nervous system conditions. The category spans neurostimulation systems, stereotactic and navigation platforms, neuroendoscopy tools, cranial fixation systems, cerebrospinal fluid management devices, neurosurgical drills and microscopes, neurovascular devices, ultrasonic aspirators, robotic-assisted platforms, and intraoperative monitoring technologies. Adoption is being shaped by the shift toward minimally invasive neurosurgery, image-guided intervention, precision targeting, and improved perioperative safety. Regulatory scrutiny remains high because these devices are often implantable, life-sustaining, or used in critical neuroanatomical procedures, making clinical evidence, biocompatibility, cybersecurity, and post-market surveillance essential. Demand is also influenced by the increasing use of advanced imaging, hybrid operating rooms, interventional neuroradiology, and multidisciplinary care pathways. As hospitals prioritize shorter procedure times, reduced complications, and better functional outcomes, neurosurgery device strategies are moving beyond hardware performance toward integrated procedural ecosystems that combine imaging, navigation, planning software, robotics, AI-enabled decision support, and longitudinal patient monitoring.

Transformative Shifts Reshaping Neurosurgery Device Adoption

The neurosurgery devices landscape is undergoing a structural transformation driven by minimally invasive techniques, real-time imaging, and connected surgical platforms. Traditional open neurosurgical workflows are being complemented by endoscopic, catheter-based, stereotactic, and robotic-assisted approaches that aim to reduce tissue disruption and improve targeting accuracy. Navigation systems are increasingly integrated with MRI, CT, angiography, tractography, and intraoperative ultrasound, allowing clinicians to visualize lesions, functional pathways, vascular structures, and implant trajectories with greater confidence. Neurovascular intervention continues to expand as mechanical thrombectomy, aneurysm management, embolization, and flow diversion technologies reshape the treatment of acute and chronic cerebrovascular disease. Implantable neuromodulation is also evolving, with deep brain stimulation, responsive stimulation, spinal cord stimulation, and peripheral nerve stimulation benefiting from improved programming, rechargeable systems, closed-loop sensing, and patient-specific therapy settings. At the same time, procurement decisions are shifting toward platforms that support interoperability, surgeon training, remote collaboration, sterilization efficiency, and evidence-based clinical protocols. The competitive environment is increasingly influenced by regulatory compliance, clinical data quality, manufacturing resilience, and the ability to support hospitals through education, maintenance, software updates, and procedural workflow optimization.

Cumulative Impact of Artificial Intelligence on Neurosurgery Devices

Artificial intelligence is adding a new layer of intelligence across the neurosurgery device value chain, from preoperative planning to postoperative follow-up. In surgical planning, AI-enabled image segmentation can support identification of tumors, hemorrhage, ventricular anatomy, vascular lesions, and eloquent brain regions, helping teams refine access routes and reduce avoidable risk. Intraoperatively, machine learning can enhance navigation accuracy, support microscope and endoscope visualization, assist robotic positioning, and analyze neurophysiological signals during functional mapping and monitoring. In neurovascular care, AI-based imaging triage has demonstrated utility in accelerating stroke workflow by flagging large vessel occlusion, perfusion mismatch, and hemorrhage patterns for time-sensitive intervention. For implantable neuromodulation, AI and advanced algorithms are enabling adaptive stimulation, symptom-state detection, and therapy personalization using physiologic signals and patient-reported outcomes. The cumulative impact is a move toward data-rich neurosurgical ecosystems that combine imaging, device telemetry, electronic health records, and clinical decision support. However, adoption depends on explainability, validation across diverse patient populations, cybersecurity safeguards, regulatory alignment, and clinician oversight. Industry leaders must treat AI not as a standalone feature but as a clinically governed capability embedded into safe, auditable, and interoperable neurosurgery workflows.

Key Regional Insights Across Global Neurosurgery Device Markets

Europe benefits from structured regulatory oversight, academic neurosurgery networks, universal or publicly supported healthcare systems, and strong uptake of image-guided surgery, neuromodulation, neurovascular care, and stereotactic procedures, while procurement timelines and health technology assessment requirements place clear emphasis on evidence, safety, traceability, and cost-effectiveness. Asia-Pacific is experiencing rapid neurosurgery device modernization due to expanding tertiary hospital networks, increasing stroke and trauma care capacity, and growing investment in advanced imaging, robotic surgery, and interventional neuroradiology. China, Japan, India, South Korea, and Australia are important drivers of neurosurgical technology adoption, though access varies significantly between metropolitan centers and rural regions. North America remains highly influential because of strong specialized neurosurgery programs, established reimbursement pathways for many advanced procedures, robust clinical trial activity, and broad use of navigation, neuromodulation, neurovascular intervention, and intraoperative imaging. Latin America is gradually strengthening neurosurgical capacity, with Brazil and Mexico leading adoption in large urban hospitals while public-sector budget constraints, import dependency, and uneven specialist availability continue to affect access. The Middle East is investing in advanced hospital infrastructure, specialist centers, and medical technology modernization, particularly in Gulf economies, with neurosurgery device adoption linked to national healthcare transformation programs and international clinical partnerships. Africa presents substantial unmet need in trauma, hydrocephalus, epilepsy, congenital conditions, and tumor care, but adoption is constrained by limited neurosurgical workforce density, imaging availability, operating room resources, maintenance infrastructure, and affordability; nonetheless, training partnerships, telemedicine, and targeted investments are improving access in selected urban referral centers.

Key Group Insights for Neurosurgery Device Strategy

NATO member countries include several of the world's most advanced military and civilian trauma systems, where neurosurgery device demand is connected to traumatic brain injury management, neurocritical care, rehabilitation pathways, surgical readiness, and resilient medical supply chains. G7 countries generally demonstrate mature neurosurgery device utilization due to advanced hospital systems, specialist density, clinical research infrastructure, and established pathways for complex cranial, spinal, neurovascular, and functional neurosurgery. The European Union emphasizes patient safety, clinical evidence, traceability, and post-market performance under stringent medical device regulation, creating a strong environment for validated neurosurgery technologies while requiring manufacturers to maintain robust clinical documentation and quality systems. BRICS economies represent a diverse growth environment, with Brazil, Russia, India, China, and South Africa each balancing demand for advanced neurosurgical care against access disparities, domestic manufacturing priorities, public procurement rules, and regional healthcare capacity gaps. ASEAN countries are advancing neurosurgery device adoption through expanding hospital infrastructure, broader access to CT and MRI, and rising demand for stroke, trauma, spine, and brain tumor care, although procurement capacity and specialist availability differ widely across member states. The GCC is characterized by substantial investment in advanced tertiary hospitals, international accreditation, digital health programs, and specialist recruitment, supporting adoption of high-end neurosurgical navigation, robotics, neurovascular platforms, and neuromodulation technologies.

Key Country Insights Shaping Neurosurgery Device Demand

The United States is a major center for neurosurgery device innovation and clinical adoption, supported by high procedure volumes, specialist hospitals, advanced imaging availability, and strong use of neurovascular, neuromodulation, navigation, and robotic-assisted technologies. China is rapidly scaling neurosurgical capacity through hospital modernization, domestic device development, stroke-center expansion, and increasing investment in robotic and digital surgery. Germany has a highly developed hospital infrastructure, substantial neurosurgical specialization, and strong adoption of navigation, intraoperative imaging, neurovascular intervention, and functional neurosurgery technologies. Japan's neurosurgery device environment is highly sophisticated, with strong use of neurovascular technologies, stereotactic approaches, imaging, and functional neurosurgery supported by an aging population and advanced hospital systems. India faces high unmet need across neurotrauma, stroke, congenital disorders, spine disease, and tumors, with advanced device adoption concentrated in metropolitan private and tertiary public institutions. The United Kingdom's adoption is influenced by national care pathways, specialist neuroscience centers, and structured health technology evaluation, with strong emphasis on clinical evidence and cost-effectiveness. Canada's neurosurgery environment is shaped by universal healthcare delivery, regional referral networks, and evidence-based procurement, with access influenced by provincial budgets and wait-time management. France combines advanced academic neurosurgery, neurovascular expertise, and reimbursement oversight, supporting adoption where devices demonstrate clear clinical value. Brazil has one of Latin America's largest neurosurgical bases, with strong demand for trauma, stroke, tumor, spine, and hydrocephalus care, although import costs and public-sector resource limitations remain relevant. Mexico is expanding advanced neurosurgical capabilities in major urban centers, while disparities between private and public systems affect access to high-cost implants and capital equipment. Australia benefits from strong specialist referral networks, high clinical standards, and adoption of advanced navigation, neurovascular, and neuromodulation technologies in major centers. Italy and Spain have well-established neurosurgery networks, with adoption shaped by regional healthcare administration, academic centers, and demand for minimally invasive and image-guided procedures. South Korea is a technologically advanced market with strong hospital digitalization, neurosurgical expertise, robotic surgery interest, and rapid integration of imaging-guided and minimally invasive approaches. Russia maintains significant neurosurgical capability in major centers, though technology access can vary by region and is affected by procurement and supply chain considerations.

Actionable Recommendations for Neurosurgery Device Leaders

Industry leaders should prioritize clinically validated innovation that improves procedural accuracy, reduces complications, and supports measurable patient outcomes. Product development should focus on interoperability with imaging, navigation, robotics, electronic health records, and hospital cybersecurity frameworks, as neurosurgery teams increasingly prefer integrated procedural ecosystems over isolated devices. Manufacturers and solution providers should invest in surgeon education, simulation-based training, proctoring models, and service infrastructure, particularly in emerging regions where workforce development and maintenance capacity directly influence adoption. Regulatory strategy must be proactive, with strong clinical evidence plans, post-market surveillance, human factors validation, software lifecycle governance, and AI transparency where digital decision support is embedded. Supply chain resilience should be strengthened through dual sourcing, component traceability, sterilization compatibility, and regional service capabilities. Commercial strategies should align with hospital value priorities, including operating room efficiency, length-of-stay reduction, complication avoidance, device durability, and total cost of ownership. In emerging healthcare systems, modular platforms, scalable configurations, financing support, and training partnerships can improve access while maintaining safety standards. For AI-enabled neurosurgery devices, leaders should emphasize explainability, clinician control, bias assessment, privacy protection, and real-world performance monitoring.

Research Methodology Based on Verified Industry Evidence

This executive summary is developed using a secondary research methodology focused on verified public-domain and institutionally credible sources. The analysis draws on medical device regulatory guidance, peer-reviewed neurosurgery and neurointerventional literature, public health data on neurological disease burden, clinical practice guidelines, hospital technology adoption patterns, reimbursement and health technology assessment frameworks, and documented trends in imaging, neuromodulation, neurovascular intervention, robotics, and AI-enabled surgical support. Regional, group, and country insights are synthesized from healthcare infrastructure indicators, specialist capacity trends, regulatory environments, public procurement dynamics, and published evidence on neurological care access. The methodology excludes market sizing, market share calculation, financial forecasting, and speculative estimates. Insights are triangulated across multiple source types to ensure consistency, relevance, and evidence alignment, while narrative interpretation is limited to observable industry developments and data-supported healthcare trends. The research approach emphasizes clinical utility, regulatory readiness, technology adoption drivers, access barriers, and strategic implications for stakeholders across the neurosurgery devices ecosystem.

Conclusion: The Future of Neurosurgery Devices Is Integrated and Evidence-Led

Neurosurgery devices are entering a new phase defined by precision intervention, digital integration, AI-assisted workflow support, and increasing demand for safer, less invasive neurological care. Hospitals and clinicians are seeking technologies that enhance visualization, navigation, tissue preservation, implant performance, neurophysiological monitoring, and treatment personalization. Regional adoption will continue to depend on specialist capacity, imaging infrastructure, reimbursement, regulatory requirements, procurement priorities, and training ecosystems. Mature healthcare systems are advancing integrated surgical platforms and AI-enabled capabilities, while emerging markets are focused on expanding essential neurosurgical access and scalable advanced care. Industry leaders that combine robust clinical evidence, interoperable design, regulatory excellence, service reliability, and education-driven adoption will be best positioned to support the evolving needs of neurosurgeons and patients. The most durable opportunities will come from solutions that demonstrate clear clinical value, improve workflow efficiency, and maintain trust in high-stakes neurological procedures.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. New Revenue Opportunities
  • 3.5. Next-Generation Business Models
  • 3.6. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Neurosurgery Devices Market, by Product Type

  • 7.1. Introduction
  • 7.2. Neurostimulation Devices
    • 7.2.1. Spinal Cord Stimulators
    • 7.2.2. Deep Brain Stimulators
    • 7.2.3. Vagus Nerve Stimulators
  • 7.3. Neurointerventional Devices
    • 7.3.1. Cerebral Aneurysm Coils
    • 7.3.2. Neurovascular Stents
  • 7.4. Surgical Navigation Systems
    • 7.4.1. Image-Guided Navigation Systems
    • 7.4.2. Electromagnetic (EM) Navigation
    • 7.4.3. Robotic-Assisted Navigation
    • 7.4.4. Intraoperative Mapping Systems
  • 7.5. Endoscopes
  • 7.6. Implantable Devices

8. Neurosurgery Devices Market, by Procedure Type

  • 8.1. Introduction
  • 8.2. Endoscopic Surgery
  • 8.3. Laser Therapy
  • 8.4. Open Surgery

9. Neurosurgery Devices Market, by Patient Type

  • 9.1. Introduction
  • 9.2. Adult Patients
  • 9.3. Pediatric Patients
  • 9.4. Geriatric Patients

10. Neurosurgery Devices Market, by Application

  • 10.1. Introduction
  • 10.2. Tumor Surgery
  • 10.3. Epilepsy
  • 10.4. Vascular / Stroke Treatment
  • 10.5. Hydrocephalus Treatment
  • 10.6. Trauma & Emergency Neurosurgery
  • 10.7. Spinal Cord Disorders

11. Neurosurgery Devices Market, by End User

  • 11.1. Introduction
  • 11.2. Hospitals & Specialty Clinics
  • 11.3. Ambulatory Surgical Centers
  • 11.4. Research & Academic Institutes

12. Neurosurgery Devices Market, by Distribution Channel

  • 12.1. Introduction
  • 12.2. Direct Sales
  • 12.3. Online Sales
  • 12.4. Distributors

13. Neurosurgery Devices Market, by Region

  • 13.1. Europe
  • 13.2. Asia-Pacific
  • 13.3. North America
  • 13.4. Latin America
  • 13.5. Middle East
  • 13.6. Africa

14. Neurosurgery Devices Market, by Group

  • 14.1. NATO
  • 14.2. G7
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. ASEAN
  • 14.6. GCC

15. Neurosurgery Devices Market, by Country

  • 15.1. United States
  • 15.2. China
  • 15.3. Germany
  • 15.4. Japan
  • 15.5. India
  • 15.6. United Kingdom
  • 15.7. Canada
  • 15.8. France
  • 15.9. Brazil
  • 15.10. Mexico
  • 15.11. Australia
  • 15.12. Italy
  • 15.13. South Korea
  • 15.14. Russia
  • 15.15. Spain

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2025
  • 16.2. FPNV Positioning Matrix, 2025
  • 16.3. Market Concentration Analysis, 2025
    • 16.3.1. Concentration Ratio (CR)
    • 16.3.2. Herfindahl Hirschman Index (HHI)
  • 16.4. Recent Developments & Impact Analysis, 2025
  • 16.5. Product Portfolio Analysis, 2025
  • 16.6. Benchmarking Analysis, 2025

17. Company Profiles

  • 17.1. Medtronic PLC
  • 17.2. Johnson & Johnson Services, Inc.
  • 17.3. Stryker Corporation
  • 17.4. Boston Scientific Corporation
  • 17.5. Zimmer Biomet Holdings, Inc.
  • 17.6. Abbott Laboratories
  • 17.7. Danaher Corporation
  • 17.8. B. Braun AG
  • 17.9. Koninklijke Philips N.V.
  • 17.10. Siemens Healthineers AG
  • 17.11. Olympus Corporation
  • 17.12. Terumo Corporation
  • 17.13. LivaNova PLC
  • 17.14. Natus Medical Incorporated
  • 17.15. Integra LifeSciences Corporation
  • 17.16. KLS Martin SE & Co. KG
  • 17.17. NAKANISHI INC.
  • 17.18. Accuray Incorporated
  • 17.19. Renishaw plc
  • 17.20. ASAHI INTECC CO., LTD.
  • 17.21. Globus Medical, Inc.
  • 17.22. Synaptive Medical Inc.
  • 17.23. ClearPoint Neuro, Inc.
  • 17.24. Adeor Medical AG
  • 17.25. Brainlab SE
  • 17.26. Elekta AB
  • 17.27. iVascular S.L.U.
  • 17.28. Luciole Medical AG
  • 17.29. NeuroPace, Inc.
  • 17.30. NuVasive, Inc.
  • 17.31. Rebstock Instruments GmbH
  • 17.32. Route 92 Medical, Inc.
  • 17.33. Scientia Vascular, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL NEUROSURGERY DEVICES MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL NEUROSURGERY DEVICES MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL NEUROSURGERY DEVICES MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL NEUROSURGERY DEVICES MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
  • FIGURE 7. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY PATIENT TYPE, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY PATIENT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY END USER, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 22. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 23. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 24. GLOBAL NEUROSURGERY DEVICES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 25. GLOBAL NEUROSURGERY DEVICES MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025

LIST OF TABLES

  • TABLE 1. GLOBAL NEUROSURGERY DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL NEUROSTIMULATION DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL NEUROSTIMULATION DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL NEUROSTIMULATION DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL SPINAL CORD STIMULATORS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL SPINAL CORD STIMULATORS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL SPINAL CORD STIMULATORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL DEEP BRAIN STIMULATORS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL DEEP BRAIN STIMULATORS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL DEEP BRAIN STIMULATORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL VAGUS NERVE STIMULATORS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL VAGUS NERVE STIMULATORS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL VAGUS NERVE STIMULATORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL NEUROINTERVENTIONAL DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL NEUROINTERVENTIONAL DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL NEUROINTERVENTIONAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL CEREBRAL ANEURYSM COILS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL CEREBRAL ANEURYSM COILS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL CEREBRAL ANEURYSM COILS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL NEUROVASCULAR STENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL NEUROVASCULAR STENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL NEUROVASCULAR STENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL SURGICAL NAVIGATION SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL SURGICAL NAVIGATION SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL SURGICAL NAVIGATION SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL IMAGE-GUIDED NAVIGATION SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL IMAGE-GUIDED NAVIGATION SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL IMAGE-GUIDED NAVIGATION SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL ELECTROMAGNETIC (EM) NAVIGATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL ELECTROMAGNETIC (EM) NAVIGATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL ELECTROMAGNETIC (EM) NAVIGATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL ROBOTIC-ASSISTED NAVIGATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL ROBOTIC-ASSISTED NAVIGATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL ROBOTIC-ASSISTED NAVIGATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL INTRAOPERATIVE MAPPING SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL INTRAOPERATIVE MAPPING SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL INTRAOPERATIVE MAPPING SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL ENDOSCOPES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL ENDOSCOPES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL ENDOSCOPES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL IMPLANTABLE DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL IMPLANTABLE DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL IMPLANTABLE DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL ENDOSCOPIC SURGERY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL ENDOSCOPIC SURGERY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL ENDOSCOPIC SURGERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL LASER THERAPY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL LASER THERAPY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL LASER THERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL OPEN SURGERY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL OPEN SURGERY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL OPEN SURGERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL ADULT PATIENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL ADULT PATIENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL ADULT PATIENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL PEDIATRIC PATIENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL PEDIATRIC PATIENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL PEDIATRIC PATIENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL GERIATRIC PATIENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL GERIATRIC PATIENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL GERIATRIC PATIENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL TUMOR SURGERY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL TUMOR SURGERY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL TUMOR SURGERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL EPILEPSY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL EPILEPSY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL EPILEPSY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL VASCULAR / STROKE TREATMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL VASCULAR / STROKE TREATMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL VASCULAR / STROKE TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL HYDROCEPHALUS TREATMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL HYDROCEPHALUS TREATMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL HYDROCEPHALUS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL TRAUMA & EMERGENCY NEUROSURGERY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL TRAUMA & EMERGENCY NEUROSURGERY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL TRAUMA & EMERGENCY NEUROSURGERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL SPINAL CORD DISORDERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL SPINAL CORD DISORDERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL SPINAL CORD DISORDERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL HOSPITALS & SPECIALTY CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL HOSPITALS & SPECIALTY CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL HOSPITALS & SPECIALTY CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL RESEARCH & ACADEMIC INSTITUTES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL RESEARCH & ACADEMIC INSTITUTES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL RESEARCH & ACADEMIC INSTITUTES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL DIRECT SALES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL DIRECT SALES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL DIRECT SALES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL ONLINE SALES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL ONLINE SALES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL ONLINE SALES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL DISTRIBUTORS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL DISTRIBUTORS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL DISTRIBUTORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPE NEUROSURGERY DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 107. EUROPE NEUROSURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 108. EUROPE NEUROSURGERY DEVICES MARKET SIZE, BY NEUROSTIMULATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 109. EUROPE NEUROSURGERY DEVICES MARKET SIZE, BY NEUROINTERVENTIONAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 110. EUROPE NEUROSURGERY DEVICES MARKET SIZE, BY SURGICAL NAVIGATION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 111. EUROPE NEUROSURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 112. EUROPE NEUROSURGERY DEVICES MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 113. EUROPE NEUROSURGERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 114. EUROPE NEUROSURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 115. EUROPE NEUROSURGERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 116. ASIA-PACIFIC NEUROSURGERY DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 117. ASIA-PACIFIC NEUROSURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 118. ASIA-PACIFIC NEUROSURGERY DEVICES MARKET SIZE, BY NEUROSTIMULATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 119. ASIA-PACIFIC NEUROSURGERY DEVICES MARKET SIZE, BY NEUROINTERVENTIONAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 120. ASIA-PACIFIC NEUROSURGERY DEVICES MARKET SIZE, BY SURGICAL NAVIGATION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 121. ASIA-PACIFIC NEUROSURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 122. ASIA-PACIFIC NEUROSURGERY DEVICES MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 123. ASIA-PACIFIC NEUROSURGERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 124. ASIA-PACIFIC NEUROSURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 125. ASIA-PACIFIC NEUROSURGERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 126. NORTH AMERICA NEUROSURGERY DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 127. NORTH AMERICA NEUROSURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 128. NORTH AMERICA NEUROSURGERY DEVICES MARKET SIZE, BY NEUROSTIMULATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 129. NORTH AMERICA NEUROSURGERY DEVICES MARKET SIZE, BY NEUROINTERVENTIONAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 130. NORTH AMERICA NEUROSURGERY DEVICES MARKET SIZE, BY SURGICAL NAVIGATION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 131. NORTH AMERICA NEUROSURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 132. NORTH AMERICA NEUROSURGERY DEVICES MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 133. NORTH AMERICA NEUROSURGERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 134. NORTH AMERICA NEUROSURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 135. NORTH AMERICA NEUROSURGERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 136. LATIN AMERICA NEUROSURGERY DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 137. LATIN AMERICA NEUROSURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 138. LATIN AMERICA NEUROSURGERY DEVICES MARKET SIZE, BY NEUROSTIMULATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 139. LATIN AMERICA NEUROSURGERY DEVICES MARKET SIZE, BY NEUROINTERVENTIONAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 140. LATIN AMERICA NEUROSURGERY DEVICES MARKET SIZE, BY SURGICAL NAVIGATION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 141. LATIN AMERICA NEUROSURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 142. LATIN AMERICA NEUROSURGERY DEVICES MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 143. LATIN AMERICA NEUROSURGERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 144. LATIN AMERICA NEUROSURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 145. LATIN AMERICA NEUROSURGERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 146. MIDDLE EAST NEUROSURGERY DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 147. MIDDLE EAST NEUROSURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 148. MIDDLE EAST NEUROSURGERY DEVICES MARKET SIZE, BY NEUROSTIMULATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 149. MIDDLE EAST NEUROSURGERY DEVICES MARKET SIZE, BY NEUROINTERVENTIONAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 150. MIDDLE EAST NEUROSURGERY DEVICES MARKET SIZE, BY SURGICAL NAVIGATION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 151. MIDDLE EAST NEUROSURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 152. MIDDLE EAST NEUROSURGERY DEVICES MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 153. MIDDLE EAST NEUROSURGERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 154. MIDDLE EAST NEUROSURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 155. MIDDLE EAST NEUROSURGERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 156. AFRICA NEUROSURGERY DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 157. AFRICA NEUROSURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 158. AFRICA NEUROSURGERY DEVICES MARKET SIZE, BY NEUROSTIMULATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 159. AFRICA NEUROSURGERY DEVICES MARKET SIZE, BY NEUROINTERVENTIONAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 160. AFRICA NEUROSURGERY DEVICES MARKET SIZE, BY SURGICAL NAVIGATION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 161. AFRICA NEUROSURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 162. AFRICA NEUROSURGERY DEVICES MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 163. AFRICA NEUROSURGERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 164. AFRICA NEUROSURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 165. AFRICA NEUROSURGERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 166. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 167. NATO NEUROSURGERY DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 168. NATO NEUROSURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 169. NATO NEUROSURGERY DEVICES MARKET SIZE, BY NEUROSTIMULATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 170. NATO NEUROSURGERY DEVICES MARKET SIZE, BY NEUROINTERVENTIONAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 171. NATO NEUROSURGERY DEVICES MARKET SIZE, BY SURGICAL NAVIGATION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 172. NATO NEUROSURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 173. NATO NEUROSURGERY DEVICES MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 174. NATO NEUROSURGERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 175. NATO NEUROSURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 176. NATO NEUROSURGERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 177. G7 NEUROSURGERY DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 178. G7 NEUROSURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 179. G7 NEUROSURGERY DEVICES MARKET SIZE, BY NEUROSTIMULATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 180. G7 NEUROSURGERY DEVICES MARKET SIZE, BY NEUROINTERVENTIONAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 181. G7 NEUROSURGERY DEVICES MARKET SIZE, BY SURGICAL NAVIGATION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 182. G7 NEUROSURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 183. G7 NEUROSURGERY DEVICES MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 184. G7 NEUROSURGERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 185. G7 NEUROSURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 186. G7 NEUROSURGERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 187. EUROPEAN UNION NEUROSURGERY DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 188. EUROPEAN UNION NEUROSURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 189. EUROPEAN UNION NEUROSURGERY DEVICES MARKET SIZE, BY NEUROSTIMULATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 190. EUROPEAN UNION NEUROSURGERY DEVICES MARKET SIZE, BY NEUROINTERVENTIONAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 191. EUROPEAN UNION NEUROSURGERY DEVICES MARKET SIZE, BY SURGICAL NAVIGATION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 192. EUROPEAN UNION NEUROSURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 193. EUROPEAN UNION NEUROSURGERY DEVICES MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 194. EUROPEAN UNION NEUROSURGERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 195. EUROPEAN UNION NEUROSURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 196. EUROPEAN UNION NEUROSURGERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 197. BRICS NEUROSURGERY DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 198. BRICS NEUROSURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 199. BRICS NEUROSURGERY DEVICES MARKET SIZE, BY NEUROSTIMULATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 200. BRICS NEUROSURGERY DEVICES MARKET SIZE, BY NEUROINTERVENTIONAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 201. BRICS NEUROSURGERY DEVICES MARKET SIZE, BY SURGICAL NAVIGATION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 202. BRICS NEUROSURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 203. BRICS NEUROSURGERY DEVICES MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 204. BRICS NEUROSURGERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 205. BRICS NEUROSURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 206. BRICS NEUROSURGERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 207. ASEAN NEUROSURGERY DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 208. ASEAN NEUROSURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 209. ASEAN NEUROSURGERY DEVICES MARKET SIZE, BY NEUROSTIMULATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 210. ASEAN NEUROSURGERY DEVICES MARKET SIZE, BY NEUROINTERVENTIONAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 211. ASEAN NEUROSURGERY DEVICES MARKET SIZE, BY SURGICAL NAVIGATION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 212. ASEAN NEUROSURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 213. ASEAN NEUROSURGERY DEVICES MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 214. ASEAN NEUROSURGERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 215. ASEAN NEUROSURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 216. ASEAN NEUROSURGERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 217. GCC NEUROSURGERY DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 218. GCC NEUROSURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 219. GCC NEUROSURGERY DEVICES MARKET SIZE, BY NEUROSTIMULATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 220. GCC NEUROSURGERY DEVICES MARKET SIZE, BY NEUROINTERVENTIONAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 221. GCC NEUROSURGERY DEVICES MARKET SIZE, BY SURGICAL NAVIGATION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 222. GCC NEUROSURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 223. GCC NEUROSURGERY DEVICES MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 224. GCC NEUROSURGERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 225. GCC NEUROSURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 226. GCC NEUROSURGERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 227. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 228. UNITED STATES NEUROSURGERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 229. UNITED STATES NEUROSURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 230. UNITED STATES NEUROSURGERY DEVICES MARKET SIZE, BY NEUROSTIMULATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 231. UNITED STATES NEUROSURGERY DEVICES MARKET SIZE, BY NEUROINTERVENTIONAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 232. UNITED STATES NEUROSURGERY DEVICES MARKET SIZE, BY SURGICAL NAVIGATION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 233. UNITED STATES NEUROSURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 234. UNITED STATES NEUROSURGERY DEVICES MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 235. UNITED STATES NEUROSURGERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 236. UNITED STATES NEUROSURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 237. UNITED STATES NEUROSURGERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 238. CHINA NEUROSURGERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 239. CHINA NEUROSURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 240. CHINA NEUROSURGERY DEVICES MARKET SIZE, BY NEUROSTIMULATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 241. CHINA NEUROSURGERY DEVICES MARKET SIZE, BY NEUROINTERVENTIONAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 242. CHINA NEUROSURGERY DEVICES MARKET SIZE, BY SURGICAL NAVIGATION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 243. CHINA NEUROSURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 244. CHINA NEUROSURGERY DEVICES MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 245. CHINA NEUROSURGERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 246. CHINA NEUROSURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 247. CHINA NEUROSURGERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 248. GERMANY NEUROSURGERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 249. GERMANY NEUROSURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 250. GERMANY NEUROSURGERY DEVICES MARKET SIZE, BY NEUROSTIMULATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 251. GERMANY NEUROSURGERY DEVICES MARKET SIZE, BY NEUROINTERVENTIONAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 252. GERMANY NEUROSURGERY DEVICES MARKET SIZE, BY SURGICAL NAVIGATION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 253. GERMANY NEUROSURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 254. GERMANY NEUROSURGERY DEVICES MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 255. GERMANY NEUROSURGERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 256. GERMANY NEUROSURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 257. GERMANY NEUROSURGERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 258. JAPAN NEUROSURGERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 259. JAPAN NEUROSURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 260. JAPAN NEUROSURGERY DEVICES MARKET SIZE, BY NEUROSTIMULATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 261. JAPAN NEUROSURGERY DEVICES MARKET SIZE, BY NEUROINTERVENTIONAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 262. JAPAN NEUROSURGERY DEVICES MARKET SIZE, BY SURGICAL NAVIGATION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 263. JAPAN NEUROSURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 264. JAPAN NEUROSURGERY DEVICES MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 265. JAPAN NEUROSURGERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 266. JAPAN NEUROSURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 267. JAPAN NEUROSURGERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 268. INDIA NEUROSURGERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 269. INDIA NEUROSURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 270. INDIA NEUROSURGERY DEVICES MARKET SIZE, BY NEUROSTIMULATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 271. INDIA NEUROSURGERY DEVICES MARKET SIZE, BY NEUROINTERVENTIONAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 272. INDIA NEUROSURGERY DEVICES MARKET SIZE, BY SURGICAL NAVIGATION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 273. INDIA NEUROSURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 274. INDIA NEUROSURGERY DEVICES MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 275. INDIA NEUROSURGERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 276. INDIA NEUROSURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 277. INDIA NEUROSURGERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 278. UNITED KINGDOM NEUROSURGERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 279. UNITED KINGDOM NEUROSURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 280. UNITED KINGDOM NEUROSURGERY DEVICES MARKET SIZE, BY NEUROSTIMULATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 281. UNITED KINGDOM NEUROSURGERY DEVICES MARKET SIZE, BY NEUROINTERVENTIONAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 282. UNITED KINGDOM NEUROSURGERY DEVICES MARKET SIZE, BY SURGICAL NAVIGATION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 283. UNITED KINGDOM NEUROSURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 284. UNITED KINGDOM NEUROSURGERY DEVICES MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 285. UNITED KINGDOM NEUROSURGERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 286. UNITED KINGDOM NEUROSURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 287. UNITED KINGDOM NEUROSURGERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 288. CANADA NEUROSURGERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 289. CANADA NEUROSURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 290. CANADA NEUROSURGERY DEVICES MARKET SIZE, BY NEUROSTIMULATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 291. CANADA NEUROSURGERY DEVICES MARKET SIZE, BY NEUROINTERVENTIONAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 292. CANADA NEUROSURGERY DEVICES MARKET SIZE, BY SURGICAL NAVIGATION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 293. CANADA NEUROSURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 294. CANADA NEUROSURGERY DEVICES MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 295. CANADA NEUROSURGERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 296. CANADA NEUROSURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 297. CANADA NEUROSURGERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 298. FRANCE NEUROSURGERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 299. FRANCE NEUROSURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 300. FRANCE NEUROSURGERY DEVICES MARKET SIZE, BY NEUROSTIMULATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 301. FRANCE NEUROSURGERY DEVICES MARKET SIZE, BY NEUROINTERVENTIONAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 302. FRANCE NEUROSURGERY DEVICES MARKET SIZE, BY SURGICAL NAVIGATION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 303. FRANCE NEUROSURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 304. FRANCE NEUROSURGERY DEVICES MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 305. FRANCE NEUROSURGERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 306. FRANCE NEUROSURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 307. FRANCE NEUROSURGERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 308. BRAZIL NEUROSURGERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 309. BRAZIL NEUROSURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 310. BRAZIL NEUROSURGERY DEVICES MARKET SIZE, BY NEUROSTIMULATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 311. BRAZIL NEUROSURGERY DEVICES MARKET SIZE, BY NEUROINTERVENTIONAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 312. BRAZIL NEUROSURGERY DEVICES MARKET SIZE, BY SURGICAL NAVIGATION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 313. BRAZIL NEUROSURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 314. BRAZIL NEUROSURGERY DEVICES MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 315. BRAZIL NEUROSURGERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 316. BRAZIL NEUROSURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 317. BRAZIL NEUROSURGERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 318. MEXICO NEUROSURGERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 319. MEXICO NEUROSURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 320. MEXICO NEUROSURGERY DEVICES MARKET SIZE, BY NEUROSTIMULATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 321. MEXICO NEUROSURGERY DEVICES MARKET SIZE, BY NEUROINTERVENTIONAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 322. MEXICO NEUROSURGERY DEVICES MARKET SIZE, BY SURGICAL NAVIGATION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 323. MEXICO NEUROSURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 324. MEXICO NEUROSURGERY DEVICES MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 325. MEXICO NEUROSURGERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 326. MEXICO NEUROSURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 327. MEXICO NEUROSURGERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 328. AUSTRALIA NEUROSURGERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 329. AUSTRALIA NEUROSURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 330. AUSTRALIA NEUROSURGERY DEVICES MARKET SIZE, BY NEUROSTIMULATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 331. AUSTRALIA NEUROSURGERY DEVICES MARKET SIZE, BY NEUROINTERVENTIONAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 332. AUSTRALIA NEUROSURGERY DEVICES MARKET SIZE, BY SURGICAL NAVIGATION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 333. AUSTRALIA NEUROSURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 334. AUSTRALIA NEUROSURGERY DEVICES MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 335. AUSTRALIA NEUROSURGERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 336. AUSTRALIA NEUROSURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 337. AUSTRALIA NEUROSURGERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 338. ITALY NEUROSURGERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 339. ITALY NEUROSURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 340. ITALY NEUROSURGERY DEVICES MARKET SIZE, BY NEUROSTIMULATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 341. ITALY NEUROSURGERY DEVICES MARKET SIZE, BY NEUROINTERVENTIONAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 342. ITALY NEUROSURGERY DEVICES MARKET SIZE, BY SURGICAL NAVIGATION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 343. ITALY NEUROSURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 344. ITALY NEUROSURGERY DEVICES MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 345. ITALY NEUROSURGERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 346. ITALY NEUROSURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)

TABLE 347.